Teva to Present at UBS Global Healthcare Conference and Jefferies London Healthcare Conference in November

Teva to Present at UBS Global Healthcare Conference and Jefferies London Healthcare Conference in November GlobeNewswire October 31, 2025 TEL AVIV, Israel, Oct. 31, 2025 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at two upcoming investor conferences in November as […]

TeraWulf Schedules Conference Call for Third Quarter 2025 Financial Results

TeraWulf Schedules Conference Call for Third Quarter 2025 Financial Results Earnings Call Set for Monday, November 10 at 4:30 p.m. ET GlobeNewswire October 31, 2025 EASTON, Md., Oct. 31, 2025 (GLOBE NEWSWIRE) — TeraWulf Inc. (Nasdaq: WULF) (“TeraWulf” or the “Company”), a leading owner and operator of vertically integrated, low-carbon digital infrastructure, today announced that

Edesa Biotech Announces Upcoming Conference Schedule

Edesa Biotech Announces Upcoming Conference Schedule GlobeNewswire October 31, 2025 TORONTO, Oct. 31, 2025 (GLOBE NEWSWIRE) — Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, announced today that Edesa management and business development staff plan to participate in the following upcoming conferences: BIO-Europe, Vienna, Austria, November 3-5,

San Antonio Same-Sex Divorce Lawyer Linda Leeser Expands Guidance For LGBTQ+ Couples In Texas

San Antonio, TX – Linda Leeser of Family Matters Law Firm PLLC (https://myfamilymatterslaw.com/san-antonio-same-sex-divorce-lawyer/) unveils an expanded set of services and resources tailored to same-sex couples, addressing the full life cycle of marriage dissolution from property division to parentage and support. The initiative centers on practical representation for those seeking a San Antonio same-sex divorce lawyer,

SuperX Reports Annual Financial Results for FY2025; Sets Stage for AI Infrastructure Growth in FY2026

FY2025 Results Reflect Legacy Operations; Major Post-Year-End Milestones Lay Foundation for Next-Phase Expansion SuperX AI Technology Limited (NASDAQ: SUPX) (“SuperX” or “the Company”), formerly Super X AI Technology Limited and Junee Limited, today announced its financial results for the fiscal year ended June 30, 2025. FY2025 represented a pivotal year of transformation as the Company

SuperX Reports Annual Financial Results for FY2025; Sets Stage for AI Infrastructure Growth in FY2026

FY2025 Results Reflect Legacy Operations; Major Post-Year-End Milestones Lay Foundation for Next-Phase Expansion SuperX AI Technology Limited (NASDAQ: SUPX) (“SuperX” or “the Company”), formerly Super X AI Technology Limited and Junee Limited, today announced its financial results for the fiscal year ended June 30, 2025. FY2025 represented a pivotal year of transformation as the Company

Global Engine Group Holding Limited Receives Nasdaq Minimum Bid Price Deficiency Notice

Global Engine Group Holding Limited Receives Nasdaq Minimum Bid Price Deficiency Notice GlobeNewswire October 31, 2025 Hong Kong, Oct. 31, 2025 (GLOBE NEWSWIRE) — Global Engine Group Holding Limited (the “Company”), a Hong Kong-headquartered integrated solutions provider in information communication technologies (“ICT”), today announced that it has received a notice (the “Notice”) from The Nasdaq

ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS

TheAberdeen Investments U.S. Closed-End Funds(NYSE: ASGI, THQ), (the “Funds” or individually the “Fund”), today announced that the Funds paid the distributions noted in the table below on October 31, 2025, on a per share basis to all shareholders of record as of October 24, 2025 (ex-dividend date October 24, 2025). https://mma.prnewswire.com/media/2698388/Aberdeen_Investments_Logo.jpg Ticker Exchange Fund AmountASGI

AgelessRx Expands Services with Medical Monitoring Support for Wegovy Patients

Ann Arbor, MI – AgelessRx, a leader in longevity-focused telehealth and medical monitoring services, today announced the launch of a new program designed to support patients seeking access to Wegovy(R) (semaglutide) through safe, expert-driven medical oversight. This offering is not a sales channel for the medication itself, but rather an integration of prescription review and

Scroll to Top